Mphasis Ltd held its Q2 FY27 earnings call on November 05, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
Strongest Sequential Growth in Three Years
Direct revenue +3.5% QoQ / +11.3% YoY CC — management's strongest sequential growth in three years, broad-based across verticals and segments.
EPS +14.6% QoQ to INR 29.4 — EBIT margin was flat sequentially; operating cash flow came in at $34 million after normalizing $39.5 million of remittances initiated September 30 and received in October.
DSO at 105 days — described by management as a quarterly aberration expected to normalize to double-digit levels in Q3 FY 2026-2027.
H1 FY 2026-2027 margin at 14.8% — at the lower end of the FY 2026-2027 guidance range of 14.75%–15.75%; the CFO declined to break out H2 within the range but remains committed to it, citing acquisition amortization and a mix shift toward on-site in short-cycle AI-led deals.
Client metrics healthy (TTM) — top 5 clients +15.1% YoY, top 10 +13%, 11–20 +22.7%; added 2 clients in the $50 million+ bracket sequentially, 3 in $20 million+ YoY and 5 in $5 million+ YoY.
Record Pipeline, Six Straight Quarters Above $400M TCV
Net new TCV of $466 million in Q2 — six consecutive quarters above $400 million; trailing 12-month TCV reached $1.8 billion; five large deals closed, including a large broker-dealer win on a recurring revenue-share model.
Total pipeline at a record, +4.4% QoQ / +23% YoY — 71% of the pipeline is AI-led, up from 12% at Mphasis.ai's launch three years ago, with the pipeline now 3x its original size; BFS pipeline +4.1% and non-BFS +4.8% QoQ.
Short-cycle momentum — sub-$20 million pipeline opportunities +35% YoY / +9% QoQ; sub-$20 million TCV +26% on a trailing 12-month basis. Management noted a $10 million 6-month deal carries the same revenue-growth propensity as a $100 million 5-year deal.
TCV ramp expected over the next 2 to 4 quarters (Q3 FY 2026-2027 through Q2 FY 2027-2028) provided conversion rates hold; management cautioned large deals are lumpy and cannot be pinned to specific close dates.
Client spend concentrated in three themes — AI engineering, cyber-estate hardening (identity and access management, non-human identity, with post-quantum cryptography work starting to be monetized), and savings-led transformation such as vendor consolidation.
Conversion robust — management said conversion, which had taken longer around FY26, is now robust with no delays to call out; better revenue conversion reflects improved short-cycle deal conversion plus robust conversion in larger deals.
AI-Led Wins Deepen; Tria Metrics Deliberately Withheld
66% of Q2 TCV wins were AI-led — up from 63% in the prior quarter; CEO Nitin Rakesh said AI-led business modernization and business imagination are "clearly emerging as themes that drive pipeline and wins," unlocking budgets beyond the technology function.
Tria monetization metrics premature — management declined to quantify Tria's share of revenue, pipeline or TCV, reiterating FY27 as a "foundational year" (as flagged in May 2026); validated deployments/metrics will be evolved and shared over the next two quarters (H2 FY 2026-2027).
Tria scaling as a proof point — now opening business-process budgets in BFS (lending origination, payment exception processing, client onboarding) and beyond; Tria-led opportunities are larger, multi-year, business-leader-sponsored deals.
Continued IP investment — management said it is too early to call when the Tria investment phase plateaus; investment will continue at least for the near future to avoid commoditization, with Tria-led delivery expected to be a margin tailwind more than offsetting the investment (margin benefit period unspecified).
Token economics easing — analyst Vibhor Singhal (Nuvama) cited token costs down almost 52% over the past 6 months; the CEO expects token costs to keep falling "even more," with token-cost optimization and workload routing across language models becoming part of Mphasis's "harnesses."
Industry context — management cited ISG's September report "The AI Value Gap," which found AI is widely used but outcomes lag, nearly half of AI budgets now sit outside IT, and model cost is only about a third of total investment.
BFS, Insurance and TMT Lead; Logistics Under Rebuild
BFS +4.5% QoQ / +15% YoY direct (8-quarter CQGR 3.8%); Insurance +1.8% QoQ / +14.7% YoY; TMT +10.9% QoQ / +14.5% YoY; on a trailing 12-month basis BFS, Insurance and TMT grew 15%, 28% and 12% respectively.
Logistics & Transportation -12% QoQ on geopolitical uncertainty; the vertical is now less than 4% of revenue in Q2 FY 2026-2027 after headwinds over the past 5-6 quarters; management is rebuilding foundations and is committed to the vertical, seeing potential for a ~$20 million/year client to scale to $50-100 million (period unspecified).
TMT now the second-biggest vertical after banking, close to insurance in size; four sub-segments — device makers, high tech, telecom (some clients breaking into the top 10), and ISVs; management responded positively to analyst-flagged peer commentary on slower tech-client spend due to AI CapEx prioritization, without quantifying forward numbers.
Geographies (direct, CC) — Americas +3.1% QoQ / +12.4% YoY; Rest of World +16.4% QoQ / +23.5% YoY led by growing participation in the GCC ecosystem; MA -3.3% QoQ / -9% YoY, reflecting revenue from a globally structured engagement allocated across regions, with underlying health intact per management.
Service lines — enterprise applications (75.6% of revenue) +3.7% QoQ / +14.4% YoY direct on AI-led modernization; BPO +6.6% QoQ / +18.7% YoY; ITO -4.9% QoQ / -21.3% YoY as integrated build-plus-run programs move into the steady run phase.
Healthcare expected to emerge as a growth driver — on the back of recent deal wins, including a large deal win in Q2 FY 2026-2027.
Q2 Cash Anomaly, Steep H2 Ask, Growth Over Margin
Q2 FY 2026-2027 cash conversion turned negative — management attributed this to a payment split across the 30th-to-1st month-end boundary (cash-in-transit no longer allowed as OCF), with almost $39 million initiated on the 30th hitting the back book on the 1st; the CFO termed it an extreme anomaly he does not expect to recur often.
Steep H2 FY 2026-2027 ask flagged by the analyst — Sandeep Shah (Equirus) noted meeting the FY 2026-2027 guidance of 80% OCF-to-PAT requires an H2 run rate upwards of 100-110%, even after adjusting for the $39.5 million collection that slipped from September (Q2) to October (Q3 FY 2026-2027).
DSO normalization is the lever — CFO Arvind Viswanathan said normalized DSOs rose ~10 days between Q1 and Q2 FY 2026-2027, which he called disappointing; pulling DSOs back on trajectory underpins the cash flow improvement expected in H2 FY 2026-2027.
Contract-acquisition outflows — against Rs.432 crore paid in FY 2025-2026 vs Rs.143 crore in H1 FY 2026-2027 (cited by the analyst), the CFO said these sit below OCF; the announced Red Oak deal carries a ~$28 million commitment with closing conditions expected to conclude in November 2026 (Q3 FY 2026-2027), and he expects such payments to be lower in FY28 than in FY27.
Cash conversion to return to historic levels in FY28 — deal-related investments made in FY 2025-2026 are playing out in FY27; the 900mn+ of net new TCV booked in H1 FY 2026-2027 involved no material cash-flow investment.
Growth prioritized over margin optimization — CEO Nitin Rakesh said Mphasis will keep prioritizing growth even if that means operating below the midpoint of the margin range, since margins are an internal optimization exercise it can "fix" while growth is client-dependent.
FY27 Guidance Raised; Risks on Long-Term Deals
FY27 revenue guidance raised to low double digits — prior guidance, given last quarter, was high single digit to low double digits; the raise cites record pipeline, backlog conversion, and six consecutive quarters of net new TCV above $400 million despite an uncertain macro environment.
FY27 profitability outlook unchanged — management continues to expect stable margins within the 14.75–15.75% band and continues to target 80% conversion of net income to operating cash flow in FY27, further normalizing in FY28.
Risk on long-term deals — client decision cycles remain difficult amid uncertainty; a "fair amount of AI noise" and the speed of change are making customers hesitant to commit to long-term deals.
Savings-led transformation deals highly competitive — management flagged that large players are willing to use their balance sheets for deal structuring and said Mphasis has to be "very cautious" in how far it goes; margin tailwinds will show only once the platform matures in steady state, and it is hard to tell if that appears immediately in Q3 or Q4 FY 2026-2027.
Furlough impact expected in line with history — the CFO said the historical organization-level furlough impact has been ~2% and he sees no reason to expect a different outcome in FY 2026-2027, with mitigation/finalization work happening in December (Q3 FY 2026-2027).
Closing tone — CEO Nitin Rakesh said the company is "not in the business of chasing AI trend cycles" and that the guidance issued on this Q2 FY 2026-2027 call reflects its confidence in the AI-led strategy.
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings